Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

VALACICLOVIR IMPURITY D CRS (10 MG)

VALACICLOVIR IMPURITY D CRS (10 MG)

NA

DISCOVER
VALACICLOVIR IMPURITY E CRS (10 MG)

VALACICLOVIR IMPURITY E CRS (10 MG)

NA

DISCOVER
VALACICLOVIR IMPURITY F PARA-TOLUENESULFONATE  CRS (20 MG)

VALACICLOVIR IMPURITY F PARA-TOLUENESULFONATE CRS (20 MG)

NA

DISCOVER
VALACICLOVIR IMPURITY G CRS (15 MG)

VALACICLOVIR IMPURITY G CRS (15 MG)

1122-58-3

DISCOVER
ITRACONAZOLE FOR SYSTEM SUITABILITY CRS (15 MG)

ITRACONAZOLE FOR SYSTEM SUITABILITY CRS (15 MG)

84625-61-6

DISCOVER
INTERFERON BETA-1A CRS (0.6 ML)

INTERFERON BETA-1A CRS (0.6 ML)

145258-61-3

DISCOVER
TEICOPLANIN CRS (50 MG)

TEICOPLANIN CRS (50 MG)

61036-62-2

DISCOVER
DIMENHYDRINATE FOR PEAK IDENTIFICATION CRS (1 MG)

DIMENHYDRINATE FOR PEAK IDENTIFICATION CRS (1 MG)

523-87-5

DISCOVER
PICOSULFATE FOR SYSTEM SUITABILITY CRS (0.5 MG)

PICOSULFATE FOR SYSTEM SUITABILITY CRS (0.5 MG)

10040-45-6

DISCOVER
DROSPIRENONE CRS (80 MG)

DROSPIRENONE CRS (80 MG)

67392-87-4

DISCOVER
MEDRONIC ACID IMPURITY B CRS (40 µL)

MEDRONIC ACID IMPURITY B CRS (40 µL)

1660-95-3

DISCOVER
MEDRONIC ACID IMPURITY A CRS (60 µL)

MEDRONIC ACID IMPURITY A CRS (60 µL)

116-17-6

DISCOVER